Leerink Partnrs Weighs in on NTLA Q1 Earnings
Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for Intellia Therapeutics in a research report issued to clients and investors on Thursday, February 27th. Leerink ...
Intellia Therapeutics price target lowered to $50 from $90 at Truist
Truist analyst Joon Lee lowered the firm’s price target on Intellia Therapeutics (NTLA) to $50 from $90 and keeps a Buy rating on the shares.
Lost Money on Intellia Therapeutics, Inc. (NTLA)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / March 3, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to ...
Le Lézard23h
NTLA LAWSUIT ALERT: The Gross Law Firm Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
The Gross Law Firm issues the following notice to shareholders of Intellia Therapeutics, Inc. . Shareholders who purchased shares ...
CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)
CRISPR Therapeutics AG ( NASDAQ: CRSP) TD Cowen 45th Annual Healthcare Conference March 3, 2025 10:30 AM ET ...
Le Lézard18h
Canadian Investment Regulatory Organization Trading Halt - HC
Hypercharge Networks Corp. TSX-Venture Symbol: HC All Issues: Yes Reason: Pending News Halt Time (ET): 10:20 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in ...
North American Morning Briefing: Stock Futures -2-
This article is a text version of a Wall Street Journal newsletter published earlier today. (END) Dow Jones Newswires ...